We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
59 result(s) found, displaying 31 to 40
-
Prescription medicine registrationActive ingredients: cabotegravir.
-
Prescription medicine registrationActive ingredients: dolutegravir sodium; lamivudine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Dolutegravir/Lamivudine
-
Prescription medicine registrationActive ingredients: dolutegravir.
-
Prescription medicine registrationActive ingredients: dolutegravir, lamivudine.
-
Cancellation by sponsorRequested by ViiV Healthcare Pty Ltd
-
Cancellation by sponsorRequested by ViiV Healthcare Pty Ltd
-
Prescription medicine registrationActive ingredients: rilpivirine hydrochloride; dolutegravir.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle.